|
Medications
Several therapies currently are approved for the prevention of osteoporosis, many of which also are approved for treatment:
|  |
|
Alendronate, raloxifene, and risedronate are approved by the U.S. Food and Drug Administration for the prevention and treatment of post-menopausal osteoporosis.
Hormone therapy (HT) is approved for the prevention of post-menopausal osteoporosis. Because of recent study results showing the risks of estrogen, it is used more selectively than before.
|
